Medical therapy for spermatogenic failure

Asian Journal of Andrology

Volumn 14, Issue 1, 2012, Pages 57-60

  Ramasamy, Ranjith ^a   Stahl, Peter J ^a   Schlegel, Peter N ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

antioxidant; hormones; male infertility; sperm; spermatogenesis; spermatogenic failure; testicular failure

Indexed keywords

ALPHA TOCOPHEROL; ANASTROZOLE; ANTIOXIDANT; BROMOCRIPTINE; CABERGOLINE; CLOMIFENE; GONADOTROPIN; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; TESTOLACTONE;

AZOOSPERMIA; HORMONAL THERAPY; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; MALE INFERTILITY; OLIGOSPERMIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPERMATOGENIC FAILURE; SPERMATOZOON COUNT; UNSPECIFIED SIDE EFFECT;

ANTIOXIDANTS; COMBINED MODALITY THERAPY; GONADOTROPINS; HUMANS; INFERTILITY, MALE; MALE; REPRODUCTIVE TECHNIQUES, ASSISTED; SPERMATOGENESIS;

EID: 84855418147     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2011.63     Document Type: Review

References (36)

1. Sokol RZ. Endocrinology of male infertility: evaluation and treatment. Semin Reprod Med 2009; 27: 149-58.
2. Kliesch S, Behre HM, Nieschlag E. High efficacy of gonadotropin or pulsatile gonadotropin-releasing hormone treatment in hypogonadotropic hypogonadal men. Eur J Endocrinol 1994; 131: 347-54. (Pubitemid 24309262)
3. Liu L, Chaudhari N, Corle D, Sherins RJ. Comparison of pulsatile subcutaneous gonadotropin-releasing hormone and exogenous gonadotropins in the treatment of men with isolated hypogonadotropic hypogonadism. Fertil Steril 1988; 49: 302-8. (Pubitemid 18047828)
4. Warne DW, Decosterd G, Okada H, Yano Y, Koide N et al. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertil Steril 2009; 92: 594-604.
5. Saleh RA, Agarwal A. Oxidative stress and male infertility: from research bench to clinical practice. J Androl 2002; 23: 737-52. (Pubitemid 36300961)
6. Bhasin S. Approach to the infertile man. J Clin Endocrinol Metab 2007; 92: 1995-2004.
7. Matsumoto AM, Snyder PJ, Bhasin S, Martin K, Weber T et al. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. Fertil Steril 2009; 92: 979-90.
8. Bouloux PM, Nieschlag E, Burger HG, Skakkebaek NE, Wu FC et al. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. J Androl 2003; 24: 604-11. (Pubitemid 38129062)
9. Liu PY, Gebski VJ, Turner L, Conway AJ, Wishart SM et al. Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. Hum Reprod 2002; 17: 625-33. (Pubitemid 34232431)
10. Spratt DI, Finkelstein JS, O'Dea LS, Badger TM, Rao PN et al. Long-term administration of gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism. A model for studies of the hormone's physiologic effects. Ann Intern Med 1986; 105: 848-55. (Pubitemid 17201758)
11. Pitteloud N, Hayes FJ, Dwyer A, Boepple PA, Lee H et al. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2002; 87: 4128-36.
12. Foresta C, Bettella A, Garolla A, Ambrosini G, Ferlin A. Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study. Fertil Steril 2005; 84: 654-61. (Pubitemid 41317724)
13. Selice R, Garolla A, Pengo M, Caretta N, Ferlin A et al. The response to FSH treatment in oligozoospermic men depends on FSH receptor gene polymorphisms. Int J Androl 2011; 34: 306-12.
14. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 273-88.
15. Vandekerckhove P, Lilford R, Vail A, Hughes E. Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev 2000; (2): CD000151.
16. Ghanem H, Shaeer O, El-Segini A. Combination clomiphene citrate and antioxidant therapy for idiopathic male infertility:arandomized controlled trial. Fertil Steril 2010; 93: 2232-5.
17. Hussein A, Ozgok Y, Ross L, Niederberger C. Clomiphene administration for cases of nonobstructive azoospermia: a multicenter study. J Androl 2005; 26: 787-91; discussion 92-3. (Pubitemid 41476639)
18. Raman JD, Schlegel PN. Aromatase inhibitors for male infertility. J Urol 2002; 167: 624-9. (Pubitemid 34074542)
19. Pavlovich CP, King P, Goldstein M, Schlegel PN. Evidence of a treatable endocrinopathy in infertile men. J Urol 2001; 165: 837-41. (Pubitemid 32156291)
20. Ramasamy R, Ricci JA, Palermo GD, Gosden LV, Rosenwaks Z et al. Successful fertility treatment for Klinefelter's syndrome. J Urol 2009; 182: 1108-13.
21. Abd-Elmoaty MA, Saleh R, Sharma R, Agarwal A. Increased levels of oxidants and reduced antioxidants in semen of infertile men with varicocele. Fertil Steril 2010; 94: 1531-4.
22. Safarinejad MR, Safarinejad S. Efficacy of selenium and/or N-acetyl-cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study. J Urol 2009; 181: 741-51.
23. Omu AE, Al-Azemi MK, Kehinde EO, Anim JT, Oriowo MA et al. Indications of the mechanisms involved in improved sperm parameters by zinc therapy. Med Princ Pract 2008; 17: 108-16. (Pubitemid 351301295)
24. Scott R, MacPherson A, Yates RW, Hussain B, Dixon J. The effect of oral selenium supplementation on human sperm motility. Br J Urol 1998; 82: 76-80. (Pubitemid 28316672)
25. Zini A, Al-Hathal N. Antioxidant therapy in male infertility: fact or fiction? Asian J Androl 2011; 13: 374-81.
26. Zini A, Phillips S, Lefebvre J, Baazeem A, Bissonnette F et al. Anti-sperm antibodies are not associated with sperm DNA damage: a prospective study of infertile men. J Reprod Immunol 2009; 85: 205-8.
27. Lopes S, Jurisicova A, Sun JG, Casper RF. Reactive oxygen species: potential cause for DNA fragmentation in human spermatozoa. Hum Reprod 1998; 13: 896-900. (Pubitemid 28239194)
28. Russo A, Troncoso N, Sanchez F, Garbarino JA, Vanella A. Propolis protects human spermatozoa from DNA damage caused by benzo[a]pyrene and exogenous reactive oxygen species. Life Sci 2006; 78: 1401-6. (Pubitemid 43233806)
29. Showell MG, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Antioxidants for male subfertility. Cochrane Database Syst Rev 2011; (1): CD007411.
30. Agarwal A, Sekhon LH. The role of antioxidant therapy in the treatment of male infertility. Hum Fertil (Camb) 2010; 13: 217-25.
31. Costa M, Canale D, Filicori M, D'Lddio S, Lenzi A. L-carnitine in idiopathic asthenozoospermia: a multicenter study. Italian Study Group on Carnitine and Male Infertility. Andrologia 1994; 26: 155-9. (Pubitemid 24192033)
32. Dawson EB, Harris WA, Teter MC, Powell LC. Effect of ascorbic acid supplementation on the sperm quality of smokers. Fertil Steril 1992; 58: 1034-9.
33. Ross C, Morriss A, Khairy M, Khalaf Y, Braude P et al. A systematic review of the effect of oral antioxidants on male infertility. Reprod Biomed Online 2010; 20: 711-23.
34. Wong WY, Merkus HM, Thomas CM, Menkveld R, Zielhuis GA et al. Effects offolic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial. Fertil Steril 2002; 77: 491-8. (Pubitemid 34177203)
35. Safarinejad MR. Effect of pentoxifylline on semen parameters, reproductive hormones, and seminal plasma antioxidant capacity in men with idiopathic infertility: a randomized double-blind placebo-controlled study. Int Urol Nephrol 2011; 43: 315-28.
36. Ko EY, Sabanegh ES Jr. The role of over the counter supplements for the treatment of male infertility-fact or fiction? J Androl; e-pub ahead of print 19 May 2011; doi:10.2164/jandrol.111.013730.